Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study.
paper
Cited
Public
Unavailable
- Authors
- Kivipelto, M; Helkala, E L; HΓ€nninen, T; Laakso, M P; Hallikainen, M; Alhainen, K; Soininen, H; Tuomilehto, J; Nissinen, A
- Year
- 2001
- Journal
- Neurology
- PMID
- 11425934
- DOI
- 10.1212/wnl.56.12.1683
OBJECTIVE: To evaluate the impact of midlife elevated serum cholesterol levels and blood pressure on the subsequent development of mild cognitive impairment (MCI) and to investigate the prevalence of MCI in elderly Finnish population, applying the MCI criteria devised by the Mayo Clinic Alzheimer's Disease Research Center. BACKGROUND: MCI has been considered as a predictor of AD. Vascular risk factors may be important in the development of cognitive impairment and AD. However, the role of vascular risk factors in MCI and the prevalence of MCI still remain virtually unknown. METHODS: Subjects were derived from random, population-based samples previously studied in surveys carried out in 1972, 1977, 1982, and 1987. After an average follow-up of 21 years, 1,449 subjects aged 65 to 79 years were reexamined in 1998. RESULTS: Eighty-two subjects, 6.1% of the population (average age, 72 years) met the criteria for MCI. Midlife elevated serum cholesterol level (> or =6.5 mmol/L) was a significant risk factor for MCI (OR, 1.9; 95% CI, 1.2 to 3.0, adjusted for age and body mass index); the effect of systolic blood pressure approached significance. CONCLUSION: Data point to a role for midlife vascular risk factors in the development of MCI in late life.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Obesity, smoking, and frontal brain dysfunction. | 2010 | 20716301 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Effects of COgNitive Training in Community-dwelling Older Adults at High Risk for demENTia (CONTENT): study protocol of two double-blind, randomised, placebo-controlled trials. | Pan Y et al. | β | 2026 | β |
| 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. | Writing Committee Members* et al. | β | 2025 | β |
| 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. | Writing Committee Members* et al. | β | 2025 | β |
| 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. | Jones DW et al. | β | 2025 | β |
| Atherogenic index of plasma and cognitive impairment risk among hypertensive adults: evidence from a nationwide cohort study. | Bai W et al. | β | 2025 | β |
| Cerebral amyloid angiopathy: a narrative review. | Noto NM et al. | β | 2025 | β |
| Cerebrovascular remodeling in aging and neurodegenerative disease progression. | Halvorsen SC et al. | β | 2025 | β |
| Connecting the dots: A narrative review of the relationship between heart failure and cognitive impairment. | Massussi M et al. | β | 2025 | β |
| CRISPR/Cas9-Based therapeutics as a promising strategy for management of Alzheimer's disease: progress and prospects. | Khan MS et al. | β | 2025 | β |
| Exploring the effect of pre-clinical Alzheimer's disease on blood pressure using Mendelian randomisation and parental dementia as an instrumental variable in UK Biobank. | Palmer JC et al. | β | 2025 | β |
| Following changes in brain structure and function with multimodal MRI in a year-long prospective study on the development of Type 2 diabetes. | Wang Y et al. | β | 2025 | β |
| Longitudinal associations between lipid panel and cognitive decline modified by APOE 4 carrier status in biracial community-dwelling older adults: Findings from the Chicago health and aging project. | Ng TKS et al. | β | 2025 | β |
| Sex-specific associations between serum lipid levels and cognitive performance in older adults: results from a cross-sectional real-world study. | Boccardi V et al. | β | 2025 | β |
| Subclinical vascular burden in relation to cognitive decline and impairment: The Multi-Ethnic Study of Atherosclerosis (MESA). | Tanley J et al. | β | 2025 | β |
| The immuno-neurological axis: association between autoimmune diseases and dementia risk. | Lee W et al. | β | 2025 | β |
| The influence of circulating cholesterol and its components in middle-aged adults on cognitive function at mid- and later-life; a systematic review. | Joyce OC et al. | β | 2025 | β |
| Thyroid function and cognitive health: rethinking the relationship between "suboptimal" TSH/FT4 levels and cognitive decline. | Dori D et al. | β | 2025 | β |
| 7-Tesla magnetic resonance imaging for monitoring microstructural changes in the lenticulostriate artery-neural complex in patients with hypertension. | Liang H et al. | β | 2024 | β |
| Addition of inflammation-related biomarkers to the CAIDE model for risk prediction of all-cause dementia, Alzheimer's disease and vascular dementia in a prospective study. | Trares K et al. | β | 2024 | β |
| Do Statins Affect Cognitive Health? A Narrative Review and Critical Analysis of the Evidence. | Kazibwe R et al. | β | 2024 | β |
| Hypertension and Cognitive Disorders. | Alagiakrishnan K et al. | β | 2024 | β |
| Hypertension, Cognitive Decline, and Mild Cognitive Impairment Among Diverse Hispanics/Latinos: Study of Latinos-Investigation of Neurocognitive Aging Results (SOL-INCA). | MΓ‘rquez F et al. | β | 2024 | β |
| Non-linear relationship between serum cholesterol levels and cognitive change among older people in the preclinical and prodromal stages of dementia: a retrospective longitudinal study in Taiwan. | Chang HT et al. | β | 2024 | β |
| Standard and New Echocardio Techniques, Such as Global Longitudinal Strain, to Monitor the Impact of Diets on Cardiovascular Diseases and Heart Function. | Sartorio A et al. | β | 2024 | β |
| The association between serum cholesterol levels and mild-to-moderate cognitive impairment in the Suita Study and evidence from other epidemiological studies. | Arafa A et al. | β | 2024 | β |
| The Relation Between Arterial Hypertension and Cognitive Impairment: A Literature Review. | ZΓΊΓ±iga Salazar G et al. | β | 2024 | β |
| The Role of Copper in Alzheimer's Disease Etiopathogenesis: An Updated Systematic Review. | Sabalic A et al. | β | 2024 | β |
| Atorvastatin mitigates memory deficits and brain monocyte infiltration in chronic hypercholesterolemia. | Gong F et al. | β | 2023 | β |
| Cholesterol-dependent amyloid Ξ² production: space for multifarious interactions between amyloid precursor protein, secretases, and cholesterol. | Rudajev V et al. | β | 2023 | β |
| Cognitive Decline in Early and Premature Menopause. | Sochocka M et al. | β | 2023 | β |
| Effects of multimodal cognitive exercise program on cognitive function, bone density, blood lipid, fitness, and depression in old women with mild cognitive impairment. | Hong SY et al. | β | 2023 | β |
| Hypertension and cognitive dysfunction: a narrative review. | Cheon EJ | β | 2023 | β |
| Hypertension management in patients with cardiovascular comorbidities. | Lauder L et al. | β | 2023 | β |
| Microvascular Contributions to Alzheimer Disease Pathogenesis: Is Alzheimer Disease Primarily an Endotheliopathy? | Tarawneh R | β | 2023 | β |
| Midlife lipid and glucose levels are associated with Alzheimer's disease. | Zhang X et al. | β | 2023 | β |
| Mild cognitive impairment among rural-dwelling older adults in China: A community-based study. | Cong L et al. | β | 2023 | β |
| Serum total cholesterol levels associated with immediate memory performance in patients with chronic schizophrenia. | Zhang G et al. | β | 2023 | β |
| Systolic blood pressure at age 40 and cognitive function 25βyears later: the Akershus Cardiac Examination (ACE) 1950 Study. | Walle-Hansen MM et al. | β | 2023 | β |
| The relationship between midlife dyslipidemia and lifetime incidence of dementia: A systematic review and meta-analysis of cohort studies. | Wee J et al. | β | 2023 | β |
| The Role of the JAK/STAT Signaling Pathway in the Pathogenesis of Alzheimer's Disease: New Potential Treatment Target. | Rusek M et al. | β | 2023 | β |
| Association of Carotid Intima Media Thickening with Future Brain Region Specific Amyloid-Ξ² Burden. | Baradaran H et al. | β | 2022 | β |
| Association of Vascular Risk Scores and Cognitive Performance in a Diverse Cohort: The Multi-Ethnic Study of Atherosclerosis. | Schaich CL et al. | β | 2022 | β |
| Blood pressure screening in midlife aids in prediction of dementia later in life. | Moberg L et al. | β | 2022 | β |
| Cholesterol as a key player in amyloid Ξ²-mediated toxicity in Alzheimer's disease. | Rudajev V et al. | β | 2022 | β |
| Exercise Normalized the Hippocampal Renin-Angiotensin System and Restored Spatial Memory Function, Neurogenesis, and Blood-Brain Barrier Permeability in the 2K1C-Hypertensive Mouse. | Chang YS et al. | β | 2022 | β |
| Higher Total Cholesterol Concentration May Be Associated with Better Cognitive Performance among Elderly Females. | Pang K et al. | β | 2022 | β |
| Highly sensitive and selective detection of cytochrome P450 46A1 activity by a ultra-high-performance liquid chromatography-tandem mass spectrometry method. | Wang S et al. | β | 2022 | β |
| Hypertension, dietary fiber intake, and cognitive function in older adults [from the National Health and Nutrition Examination Survey Data (2011-2014)]. | Zhang H et al. | β | 2022 | β |
| Midlife Vascular Factors and Prevalence of Mild Cognitive Impairment in Late-Life in Mexico. | Arce RenterΓa M et al. | β | 2022 | β |
| Vascular Contributions to Brain Health: Cross-Cutting Themes. | Greenberg SM | β | 2022 | β |
| Vascular Endothelial Growth Factor Receptor-1 Modulates Hypoxia-Mediated Endothelial Senescence and Cellular Membrane Stiffness <i>via</i> YAP-1 Pathways. | Angom RS et al. | β | 2022 | β |
| Vascular Health Is Associated With Functional Connectivity Decline in Higher-Order Networks of Older Adults. | Wirth M et al. | β | 2022 | β |
| Alzheimer's pathogenic mechanisms and underlying sex difference. | Zhu D et al. | β | 2021 | β |
| Anti-PCSK 9 antibodies increase the ratios of the brain-specific oxysterol 24S-hydroxycholesterol to cholesterol and to 27-hydroxycholesterol in the serum. | LΓΌtjohann D et al. | β | 2021 | β |
| Association of the CD2AP locus with cognitive functioning among middle-aged individuals with a family history of Alzheimer's disease. | Manzali SB et al. | β | 2021 | β |
| A Systematic Review of the Application of Functional Near-Infrared Spectroscopy to the Study of Cerebral Hemodynamics in Healthy Aging. | Yeung MK et al. | β | 2021 | β |
| Burden and correlates of cognitive impairment among hypertensive patients in Tanzania: a cross-sectional study. | Pallangyo P et al. | β | 2021 | β |
| Can platelet activation result in increased plasma AΞ² levels and contribute to the pathogenesis of Alzheimer's disease? | Carbone MG et al. | β | 2021 | β |
| Cardiovascular brain impulses in Alzheimer's disease. | Rajna Z et al. | β | 2021 | β |
| "Cerebral small vessel disease and other influential factors of cognitive impairment in the middle-aged: a long-term observational cohort PURE-MIND study in Poland". | SzczeΕniak D et al. | β | 2021 | β |
| Chronic Kidney Disease and Cognitive Impairment. | Murtaza A et al. | β | 2021 | β |
| [Cognitive impairment in patients with cardiovascular risk: DECOG study]. | Arrieta AntΓ³n E et al. | β | 2021 | β |
| Dementia Prevalence, Comorbidities, and Lifestyle Among Jatinangor Elders. | Ong PA et al. | β | 2021 | β |
| Different hypertension thresholds and cognitive decline: a pooled analysis of three ageing cohorts. | Ma Y et al. | β | 2021 | β |
| Effect of Heart Rate Reserve on Prefrontal Cortical Activation While Dual-Task Walking in Older Adults. | Bishnoi A et al. | β | 2021 | β |
| High Caloric Diet Induces Memory Impairment and Disrupts Synaptic Plasticity in Aged Rats. | Paulo SL et al. | β | 2021 | β |
| How much should LDL cholesterol be lowered in secondary prevention? Clinical efficacy and safety in the era of PCSK9 inhibitors. | Cybulska B et al. | β | 2021 | β |
| Hypertension and Alzheimer's disease: is the picture any clearer? | Lennon MJ et al. | β | 2021 | β |
| Hypertension and cognitive dysfunction: a review of mechanisms, life-course observational studies and clinical trial results. | Mahinrad S et al. | β | 2021 | β |
| Liver-Unrelated Comorbid Conditions Do Not Affect Cognitive Performance or Hepatic Encephalopathy Progression in Cirrhosis. | Acharya C et al. | β | 2021 | β |
| Midlife aerobic exercise and dynamic cerebral autoregulation: associations with baroreflex sensitivity and central arterial stiffness. | Tomoto T et al. | β | 2021 | β |
| Prediction of Cognitive Status and 5-Year Survival Rate for Elderly with Cardiovascular Diseases: A Canadian Study of Health and Aging Secondary Data Analysis. | Pakzad S et al. | β | 2021 | β |
| Sex difference in flux of 27-hydroxycholesterol into the brain. | Parrado-Fernandez C et al. | β | 2021 | β |
| The Association of Age at Diagnosis of Hypertension With Brain Structure and Incident Dementia in the UK Biobank. | Shang X et al. | β | 2021 | β |
| The MRi-Share database: brain imaging in a cross-sectional cohort of 1870 university students. | Tsuchida A et al. | β | 2021 | β |
| The relationship between heart disease and cognitive impairment. | Miller KL et al. | β | 2021 | β |
| Animal Models of Metabolic Disorders in the Study of Neurodegenerative Diseases: An Overview. | de Bem AF et al. | β | 2020 | β |
| A second X chromosome contributes to resilience in a mouse model of Alzheimer's disease. | Davis EJ et al. | β | 2020 | β |
| Association of Hypertension According to New American College of Cardiology/American Heart Association Blood Pressure Guidelines With Incident Dementia in the ARIC Study Cohort. | Hodis JD et al. | β | 2020 | β |
| Baseline Results: The Association Between Cardiovascular Risk and Preclinical Alzheimer's Disease Pathology (ASCEND) Study. | Kumar VV et al. | β | 2020 | β |
| Blood Lipids and Cognitive Performance of Aging Polish Adults: A Case-Control Study Based on the PolSenior Project. | McFarlane O et al. | β | 2020 | β |
| Blood Pressure in Different Dementia Disorders, Mild Cognitive Impairment, and Subjective Cognitive Decline. | Hestad K et al. | β | 2020 | β |
| Comprehensive Geriatric Assessment in the Management of Older Patients With Cardiovascular Disease. | Singh M et al. | β | 2020 | β |
| Determinants of Perceived Own Risk for Developing Dementia and the Perception That Memory Deterioration Is Preventable. Findings From the General Adult Population in Germany. | Hajek A et al. | β | 2020 | β |
| Hemodynamic Instability in Heart Failure Intensifies Age-Dependent Cognitive Decline. | de la Torre JC | β | 2020 | β |
| High Plasma Resistin Levels Portend the Insulin Resistance-Associated Susceptibility to Early Cognitive Decline in Patients with Type 2 Diabetes Mellitus. | Wang C et al. | β | 2020 | β |
| Late-life personality traits, cognitive impairment, and mortality in a population-based cohort. | Neuvonen E et al. | β | 2020 | β |
| Risk for Alzheimer's disease: A review of long-term episodic memory encoding and retrieval fMRI studies. | McDonough IM et al. | β | 2020 | β |
| Sex difference in Alzheimer's disease: An updated, balanced and emerging perspective on differing vulnerabilities. | Dubal DB | β | 2020 | β |
| The Apolipoprotein E Ξ΅4 Allele-Dependent Relationship Between Serum Lipid Levels and Cognitive Function: A Population-Based Cross-sectional Study. | Wei S et al. | β | 2020 | β |
| The Association Between Hypertension and Cognitive Impairment, and the Role of Antihypertensive Medications: A Literature Review. | Mishra N et al. | β | 2020 | β |
| The Effect of Blood Pressure on Cognitive Performance. An 8-Year Follow-Up of the TromsΓΈ Study, Comprising People Aged 45-74 Years. | Hestad K et al. | β | 2020 | β |
| The effect of midlife cardiovascular risk factors on white matter hyperintensity volume and cognition two decades later in normal ageing women. | Aljondi R et al. | β | 2020 | β |
| Third follow-up of the Cardiovascular Risk Factors, Aging and Dementia (CAIDE) cohort investigating determinants of cognitive, physical, and psychosocial wellbeing among the oldest old: the CAIDE85+ study protocol. | Barbera M et al. | β | 2020 | β |
| Tremor in Vascular Cognitive Impairment Raises the Possibility of Mixed Pathology With Lewy Body Disease. | Chiu PY et al. | β | 2020 | β |
| ACAT1 as a Therapeutic Target and its Genetic Relationship with Alzheimer's Disease. | Alavez-Rubio JS et al. | β | 2019 | β |
| Alzheimer's Environmental and Genetic Risk Scores are Differentially Associated With General Cognitive Ability and Dementia Severity. | Andrews SJ et al. | β | 2019 | β |
| Blood pressure and cognitive performances in middle-aged adults: the Aging, Health and Work longitudinal study. | Rouch L et al. | β | 2019 | β |
| CE: Original Research: Midlife Hypertension and Hypercholesterolemia in Relation to Cognitive Function Later in Life in Black Women. | Devore E et al. | β | 2019 | β |
| Different Relationship Between Systolic Blood Pressure and Cerebral Perfusion in Subjects With and Without Hypertension. | Glodzik L et al. | β | 2019 | β |
| Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial. | SPRINT MIND Investigators for the SPRINT Research Group et al. | β | 2019 | β |
| HDL Cholesterol Is Independently Associated with Cognitive Function in Males But Not in Females within a Cohort of Nonagenarians: The MUGELLO Study. | Pancani S et al. | β | 2019 | β |
| Interaction between apolipoprotein E genotype and hypertension on cognitive function in older women in the Nurses' Health Study. | Kim IY et al. | β | 2019 | β |
| Longitudinal Brain Atrophy Rates in Transient Ischemic Attack and Minor Ischemic Stroke Patients and Cognitive Profiles. | Munir M et al. | β | 2019 | β |
| Neurovascular and Cognitive Dysfunction in Hypertension. | Iadecola C et al. | β | 2019 | β |
| Nutritional and hematological factors associated with the progression of Alzheimer's disease: a cohort study. | GregΓ³rio E et al. | β | 2019 | β |
| Sensorineural Impairments, Cardiovascular Risk Factors, and 10-Year Incidence of Cognitive Impairment and Decline in Midlife: The Beaver Dam Offspring Study. | Schubert CR et al. | β | 2019 | β |
| Serum Insulin and Cognitive Performance in Older Adults: A Longitudinal Study. | Hooshmand B et al. | β | 2019 | β |
| Sex differences in Alzheimer's disease: Understanding the molecular impact. | Toro CA et al. | β | 2019 | β |
| The Level of Cognitive Impairment and Likelihood of Frequent Hospital Admissions. | Amini R et al. | β | 2019 | β |
| The Lifespan Human Connectome Project in Aging: An overview. | Bookheimer SY et al. | β | 2019 | β |
| 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. | Whelton PK et al. | β | 2018 | β |
| 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. | Whelton PK et al. | β | 2018 | β |
| 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. | Whelton PK et al. | β | 2018 | β |
| Angiotensin II Receptor Blockers Attenuate Lipopolysaccharide-Induced Memory Impairment by Modulation of NF-ΞΊB-Mediated BDNF/CREB Expression and Apoptosis in Spontaneously Hypertensive Rats. | Goel R et al. | β | 2018 | β |
| APOE genotype modifies the association between central arterial stiffening and cognition in older adults. | Cambronero FE et al. | β | 2018 | β |
| Association between Plasma Levels of PAI-1, tPA/PAI-1 Molar Ratio, and Mild Cognitive Impairment in Chinese Patients with Type 2 Diabetes Mellitus. | Wang J et al. | β | 2018 | β |
| Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums. | Arnold SE et al. | β | 2018 | β |
| Cardiovascular Risk Factors Are Correlated with Low Cognitive Function among Older Adults Across Europe Based on The SHARE Database. | Lourenco J et al. | β | 2018 | β |
| Chronic administration of ellagic acid improved the cognition in middle-aged overweight men. | Liu Y et al. | β | 2018 | β |
| Chronic Health Illnesses as Predictors of Mild Cognitive Impairment Among African American Older Adults. | Burke SL et al. | β | 2018 | β |
| Decreased content, rate of synthesis and export of cholesterol in the brain of apoE knockout mice. | Nunes VS et al. | β | 2018 | β |
| Developing a Non-Pharmacological Intervention for Individuals With Mild Cognitive Impairment. | Rodakowski J et al. | β | 2018 | β |
| Impaired memory is more closely associated with brain beta-amyloid than leukoaraiosis in hypertensive patients with cognitive symptoms. | Smith EE et al. | β | 2018 | β |
| Increased diastolic blood pressure is associated with MRI biomarkers of dementia-related brain pathology in normative ageing. | McNeil CJ et al. | β | 2018 | β |
| Invited Commentary: Secondhand Smoke-an Underrecognized Risk Factor for Cognitive Decline. | Anstey KJ et al. | β | 2018 | β |
| Left ventricular hypertrophy and cognitive function: a systematic review. | Restrepo C et al. | β | 2018 | β |
| Long-Term Blood Pressure Level and Variability From Midlife to Later Life and Subsequent Cognitive Change: The ARIC Neurocognitive Study. | Yano Y et al. | β | 2018 | β |
| Markers of oxidative damage to lipids, nucleic acids and proteins and antioxidant enzymes activities in Alzheimer's disease brain: A meta-analysis in human pathological specimens. | Zabel M et al. | β | 2018 | β |
| Mediators of the relationship between social activities and cognitive function among older Irish adults: results from the Irish longitudinal study on ageing. | McHugh Power J et al. | β | 2018 | β |
| Mild Cognitive Impairment in Republic of Georgia. | Janelidze M et al. | β | 2018 | β |
| Nutritional status, survival and mortality in Alzheimer patients - a cross-sectional study | de Gregorio E et al. | β | 2018 | β |
| Outcome age-based prediction of successful cognitive aging by total cholesterol. | Silverman JM et al. | β | 2018 | β |
| Practice guideline update summary: Mild cognitive impairment [RETIRED]: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. | Petersen RC et al. | β | 2018 | β |
| Small Vessel Cerebrovascular Pathology Identified by Magnetic Resonance Imaging Is Prevalent in Alzheimer's Disease and Mild Cognitive Impairment: A Potential Target for Intervention. | Scott TM et al. | β | 2018 | β |
| The association of total cholesterol with processing speed is moderated by age in mid- to late-age healthy adults. | Elkana O et al. | β | 2018 | β |
| The Physical Activity and Alzheimer's Disease (PAAD) Study: Cognitive outcomes. | Etnier JL et al. | β | 2018 | β |
| The protected survivor model: Using resistant successful cognitive aging to identify protection in the very old. | Silverman JM et al. | β | 2018 | β |
| The serum metabolomics signature of type 2 diabetes is obscured in Alzheimer's disease. | Morris JK et al. | β | 2018 | β |
| The Vascular Hypothesis of Alzheimer's Disease: A Key to Preclinical Prediction of Dementia Using Neuroimaging. | de la Torre J | β | 2018 | β |
| 27-Hydroxycholesterol regulates cholesterol synthesis and transport in C6 glioma cells. | An Y et al. | β | 2017 | β |
| Age-related decline in task switching is linked to both global and tract-specific changes in white matter microstructure. | Jolly TA et al. | β | 2017 | β |
| Association of Arterial Stiffness and Central Pressure With Cognitive Function in Incident Hemodialysis Patients: The PACE Study. | Kim ED et al. | β | 2017 | β |
| Association of JNC-8 and SPRINT Systolic Blood Pressure Levels With Cognitive Function and Related Racial Disparity. | Hajjar I et al. | β | 2017 | β |
| Blood cholesterol in late-life and cognitive decline: a longitudinal study of the Chinese elderly. | Ma C et al. | β | 2017 | β |
| Body Mass Index, Height and Socioeconomic Position in Adolescence, Their Trajectories into Adulthood, and Cognitive Function in Midlife. | Cohen-Manheim I et al. | β | 2017 | β |
| Can LDL cholesterol be too low? Possible risks of extremely low levels. | Olsson AG et al. | β | 2017 | β |
| Clinical features of incidental mild cognitive impairment and dementia in a population-based study. | Hishikawa N et al. | β | 2017 | β |
| Defining Optimal Brain Health in Adults: A Presidential Advisory From the American Heart Association/American Stroke Association. | Gorelick PB et al. | β | 2017 | β |
| Hypertension and cognitive impairment. | Aronow WS | β | 2017 | β |
| Lifestyle and Neurocognition in Older Adults With Cardiovascular Risk Factors and Cognitive Impairment. | Blumenthal JA et al. | β | 2017 | β |
| Longitudinal association of hypertension and diabetes mellitus with cognitive functioning in a general 70-year-old population: the SONIC study. | Ryuno H et al. | β | 2017 | β |
| Memory is preserved in older adults taking AT1 receptor blockers. | Ho JK et al. | β | 2017 | β |
| Midlife systemic inflammatory markers are associated with late-life brain volume: The ARIC study. | Walker KA et al. | β | 2017 | β |
| Multiple-modality exercise and mind-motor training to improve cardiovascular health and fitness in older adults at risk for cognitive impairment: A randomized controlled trial. | Boa Sorte Silva NC et al. | β | 2017 | β |
| Risk Factors for Mild Cognitive Impairment in German Primary Care Practices. | Jacob L et al. | β | 2017 | β |
| Sex differences in the prevalence and incidence of mild cognitive impairment: A meta-analysis. | Au B et al. | β | 2017 | β |
| Updating the Evidence on the Association between Serum Cholesterol and Risk ofΒ Late-Life Dementia: Review andΒ Meta-Analysis. | Anstey KJ et al. | β | 2017 | β |
| Vascular Cognitive Impairment. | Dichgans M et al. | β | 2017 | β |
| Alzheimer Disease and Its Growing Epidemic: Risk Factors, Biomarkers, and the Urgent Need for Therapeutics. | Hickman RA et al. | β | 2016 | β |
| Association of late-life changes in blood pressure and cognitive status. | Lacruz ME et al. | β | 2016 | β |
| Cerebral Perfusion Enhancing Interventions: A New Strategy for the Prevention of Alzheimer Dementia. | de la Torre JC | β | 2016 | β |
| Cognitive Impairment Among Elderly Patients With Chronic Heart Failure and Related Factors. | Taraghi Z et al. | β | 2016 | β |
| Coronary artery disease in patients with dementia. | Fowkes R et al. | β | 2016 | β |
| Effects of Meditation versus Music Listening on Perceived Stress, Mood, Sleep, and Quality of Life in Adults with Early Memory Loss: A Pilot Randomized Controlled Trial. | Innes KE et al. | β | 2016 | β |
| Executive Cognitive Functioning and Cardiovascular Autonomic Regulation in a Population-Based Sample of Working Adults. | Stenfors CU et al. | β | 2016 | β |
| From Heart Health to Brain Health: Legacy of the North Karelia Project for Dementia Research. | Kivipelto M et al. | β | 2016 | β |
| Higher Plasma LDL-Cholesterol is Associated with Preserved Executive and Fine Motor Functions in Parkinson's Disease. | Sterling NW et al. | β | 2016 | β |
| Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association. | Iadecola C et al. | β | 2016 | β |
| Impact of lifestyle-related disease on conversion and reversion in patients with mild cognitive impairment: after 12 months of follow-up. | Osone A et al. | β | 2016 | β |
| Is there an association between hypercholesterolemia and depression? Behavioral evidence from the LDLr(-/-) mouse experimental model. | Engel DF et al. | β | 2016 | β |
| Mild cognitive impairment affects motor control and skill learning. | Wu Q et al. | β | 2016 | β |
| Obtaining Information from Family Caregivers Is Important to Detect Behavioral and Psychological Symptoms and Caregiver Burden in Subjects with Mild Cognitive Impairment. | Yamagami T et al. | β | 2016 | β |
| Predictors of Long-Term Change in Adult Cognitive Performance: Systematic Review and Data from the Northern Finland Birth Cohort 1966. | Rannikko I et al. | β | 2016 | β |
| Relationship between plasma lipids and mild cognitive impairment in the elderly Chinese: a case-control study. | He Q et al. | β | 2016 | β |
| Safety Issues in Iron Treatment in CKD. | Vaziri ND | β | 2016 | β |
| Summative effects of vascular risk factors on cortical thickness in mild cognitive impairment. | Tchistiakova E et al. | β | 2016 | β |
| Using Cognitive Screening Tests in Audiology. | Shen J et al. | β | 2016 | β |
| 27-Hydroxycholesterol contributes to disruptive effects on learning and memory by modulating cholesterol metabolism in the rat brain. | Zhang DD et al. | β | 2015 | β |
| 27-hydroxycholesterol mediates negative effects of dietary cholesterol on cognition in mice. | Heverin M et al. | β | 2015 | β |
| Calcium Channel Blockers, Progression to Dementia, and Effects on Amyloid Beta Peptide Production. | Lovell MA et al. | β | 2015 | β |
| Composite cardiovascular risk scores and neuropsychological functioning: a meta-analytic review. | DeRight J et al. | β | 2015 | β |
| Cooccurrence of vascular risk factors and late-life white-matter integrity changes. | Maillard P et al. | β | 2015 | β |
| Genome instability biomarkers and blood micronutrient risk profiles associated with mild cognitive impairment and Alzheimer's disease. | Lee SL et al. | β | 2015 | β |
| Hypertension exacerbates predisposition to neurodegeneration and memory impairment in the presence of a neuroinflammatory stimulus: Protection by angiotensin converting enzyme inhibition. | Goel R et al. | β | 2015 | β |
| Impact of diabetes on cognitive function and brain structure. | Moheet A et al. | β | 2015 | β |
| Midlife Hypertension Risk and Cognition in the Non-Demented Oldest Old: Framingham Heart Study. | Nishtala A et al. | β | 2015 | β |
| Mild cognitive impairment risk factor survey of the Xinjiang Uyghur and Han elderly. | Keyimu K et al. | β | 2015 | β |
| Modulation of Renin-Angiotensin System May Slow Conversion from Mild Cognitive Impairment to Alzheimer's Disease. | Wharton W et al. | β | 2015 | β |
| Poorly controlled cholesterol is associated with cognitive impairment in T2DM: a resting-state fMRI study. | Xia W et al. | β | 2015 | β |
| Projecting Burden of Dementia in Spain, 2010-2050: Impact of Modifying Risk Factors. | Soto-Gordoa M et al. | β | 2015 | β |
| Prospective Study of Arterial Stiffness and Subsequent Cognitive Decline Among Community-Dwelling Older Japanese. | Taniguchi Y et al. | β | 2015 | β |
| The role of type 2 diabetes in neurodegeneration. | Verdile G et al. | β | 2015 | β |
| Vascular risk factors, cerebrovascular reactivity, and the default-mode brain network. | Haight TJ et al. | β | 2015 | β |
| ABO blood type, factor VIII, and incident cognitive impairment in the REGARDS cohort. | Alexander KS et al. | β | 2014 | β |
| Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers. | Reitz C et al. | β | 2014 | β |
| Characterization of a normal control group: are they healthy? | Aine CJ et al. | β | 2014 | β |
| Clinical epidemiology of Alzheimer's disease: assessing sex and gender differences. | Mielke MM et al. | β | 2014 | β |
| Cognitive decline and depressive symptoms in late-life are associated with statin use: evidence from a population-based study of Sardinian old people living in their own home. | Mandas A et al. | β | 2014 | β |
| Cognitive functioning among patients with diabetic foot. | Marseglia A et al. | β | 2014 | β |
| Coronary artery disease and plasma apolipoprotein E4 in mild cognitive impairment. | Barekatain M et al. | β | 2014 | β |
| Coronary heart disease and cortical thickness, gray matter and white matter lesion volumes on MRI. | Vuorinen M et al. | β | 2014 | β |
| Elevated LDL-C combined with hypertension worsens subclinical vascular impairment and cognitive function. | KovΓ‘cs KR et al. | β | 2014 | β |
| Imaging small vessel-associated white matter changes in aging. | Salat DH | β | 2014 | β |
| Longitudinal trajectories of cholesterol from midlife through late life according to apolipoprotein E allele status. | Downer B et al. | β | 2014 | β |
| Metabolic syndrome is associated with poor memory and executive performance in elderly community residents: the PROOF study. | Rouch I et al. | β | 2014 | β |
| Midlife cardiovascular risk impacts executive function: Framingham offspring study. | Nishtala A et al. | β | 2014 | β |
| Midlife hypertension and 20-year cognitive change: the atherosclerosis risk in communities neurocognitive study. | Gottesman RF et al. | β | 2014 | β |
| Neuroprotective pathways: lifestyle activity, brain pathology, and cognition in cognitively normal older adults. | Wirth M et al. | β | 2014 | β |
| The link between cardiovascular risk, Alzheimer's disease, and mild cognitive impairment: support from recent functional neuroimaging studies. | Ferreira LK et al. | β | 2014 | β |
| The relationship between midlife and late life alcohol consumption, APOE e4 and the decline in learning and memory among older adults. | Downer B et al. | β | 2014 | β |
| Vitamin D and neurocognitive function. | SchlΓΆgl M et al. | β | 2014 | β |
| Anthropometric indices and dietary intake: prospective determinants of geriatric cognitive impairment? | Agarwal A et al. | β | 2013 | β |
| A principal component model of medical health: implications for cognitive deficits and decline among adults in a population-based sample. | Persson N et al. | β | 2013 | β |
| Cardiovascular health through young adulthood and cognitive functioning in midlife. | Reis JP et al. | β | 2013 | β |
| Cardiovascular risk factors and cognitive decline in adults aged 50 and over: a population-based cohort study. | Dregan A et al. | β | 2013 | β |
| Cardiovascular risk profile and cognitive function in young, middle-aged, and elderly subjects. | Joosten H et al. | β | 2013 | β |
| Cerebrovascular reactivity to carbon dioxide in Alzheimer's disease. | Glodzik L et al. | β | 2013 | β |
| Changes in vascular factors 28 years from midlife and late-life cortical thickness. | Vuorinen M et al. | β | 2013 | β |
| Cholesterol and copper affect learning and memory in the rabbit. | Schreurs BG | β | 2013 | β |
| Contemplating Alzheimer's disease and the contribution of white matter hyperintensities. | Brickman AM | β | 2013 | β |
| Dementia in the oldest old. | Bullain SS et al. | β | 2013 | β |
| Diphenyl diselenide prevents cortico-cerebral mitochondrial dysfunction and oxidative stress induced by hypercholesterolemia in LDL receptor knockout mice. | de Oliveira J et al. | β | 2013 | β |
| High blood pressure and cognitive decline in mild cognitive impairment. | Goldstein FC et al. | β | 2013 | β |
| Indicators of childhood quality of education in relation to cognitive function in older adulthood. | Crowe M et al. | β | 2013 | β |
| In-hospital acute stress symptoms are associated with impairment in cognition 1 year after intensive care unit admission. | Davydow DS et al. | β | 2013 | β |
| Kampo formulations, chotosan, and yokukansan, for dementia therapy: existing clinical and preclinical evidence. | Matsumoto K et al. | β | 2013 | β |
| Midlife hypertensive status and cognitive function 20 years later: the Southall and Brent revisited study. | Taylor C et al. | β | 2013 | β |
| Midlife stroke risk and cognitive decline: a 10-year follow-up of the Whitehall II cohort study. | Kaffashian S et al. | β | 2013 | β |
| Predicting cognitive decline: a dementia risk score vs. the Framingham vascular risk scores. | Kaffashian S et al. | β | 2013 | β |
| Roles of vascular and metabolic components in cognitive dysfunction of Alzheimer disease: short- and long-term modification by non-genetic risk factors. | Sato N et al. | β | 2013 | β |
| Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults. | Mangialasche F et al. | β | 2013 | β |
| Sex-specific effects on spatial learning and memory, and sex-independent effects on blood pressure of a <3.3 Mbp rat chromosome 2 QTL region in Dahl salt-sensitive rats. | Herrera VL et al. | β | 2013 | β |
| Subgroup of ADNI normal controls characterized by atrophy and cognitive decline associated with vascular damage. | Nettiksimmons J et al. | β | 2013 | β |
| The emerging role of dietary fructose in obesity and cognitive decline. | Lakhan SE et al. | β | 2013 | β |
| The Use of Multiple Correspondence Analysis to Explore Associations between Categories of Qualitative Variables in Healthy Ageing. | Costa PS et al. | β | 2013 | β |
| Use of near-infrared spectroscopy as a measure of cerebrovascular health in aging adults. | Suhr JA et al. | β | 2013 | β |
| Vascular cognitive impairment. | Farooq MU et al. | β | 2013 | β |
| Very old adults with better memory function have higher low-density lipoprotein cholesterol levels and lower triglyceride to high-density lipoprotein cholesterol ratios: KOCOA Project. | Katsumata Y et al. | β | 2013 | β |
| A high cholesterol diet ameliorates hippocampus-related cognitive and pathological deficits in ovariectomized mice. | Li L et al. | β | 2012 | β |
| Antioxidative strategies in cognitive impairment: a novel connection between biliverdin-reductase and statins. | Schneider A et al. | β | 2012 | β |
| Associations between serum homocysteine, holotranscobalamin, folate and cognition in the elderly: a longitudinal study. | Hooshmand B et al. | β | 2012 | β |
| Atherosclerotic risk factors, vascular cognitive impairment, and Alzheimer disease. | Kovacic JC et al. | β | 2012 | β |
| AΞ² toxicity in Alzheimer's disease. | Cavallucci V et al. | β | 2012 | β |
| Calpain dysregulation in Alzheimer's disease. | Ferreira A | β | 2012 | β |
| Cholesterol: its regulation and role in central nervous system disorders. | Orth M et al. | β | 2012 | β |
| Cognitive assessment protocol design in the ISSYS (Investigating Silent Strokes in hYpertensives: a magnetic resonance imaging Study). | Riba I et al. | β | 2012 | β |
| Dysfunctional nucleus tractus solitarius: its crucial role in promoting neuropathogenetic cascade of Alzheimer's dementia--a novel hypothesis. | Daulatzai MA | β | 2012 | β |
| Effect of western and high fat diets on memory and cholinergic measures in the rat. | Kosari S et al. | β | 2012 | β |
| Insulin and sex interactions in older adults with mild cognitive impairment. | Cholerton B et al. | β | 2012 | β |
| Low-density lipoprotein receptor-related protein 1: a physiological AΞ² homeostatic mechanism with multiple therapeutic opportunities. | Sagare AP et al. | β | 2012 | β |
| Metabolic syndrome and cognitive decline among the oldest old in Okinawa: in search of a mechanism. The KOCOA Project. | Katsumata Y et al. | β | 2012 | β |
| Mild cognitive impairment: disparity of incidence and prevalence estimates. | Ward A et al. | β | 2012 | β |
| Mixed cerebrovascular disease and the future of stroke prevention. | Fisher M et al. | β | 2012 | β |
| Occurrence and risk factors of mild cognitive impairment in the older Chinese population: a 3-year follow-up study. | Hai S et al. | β | 2012 | β |
| Sex and gonadal hormones in mouse models of Alzheimer's disease: what is relevant to the human condition? | Dubal DB et al. | β | 2012 | β |
| The Association between Hypertension and Dementia in the Elderly. | Igase M et al. | β | 2012 | β |
| The links between complex coronary disease, cerebrovascular disease, and degenerative brain disease. | Kovacic JC et al. | β | 2012 | β |
| Baseline leisure time activity and cognition more than two decades later. | KΓ₯reholt I et al. | β | 2011 | β |
| Cellular senescence, vascular disease, and aging: part 2 of a 2-part review: clinical vascular disease in the elderly. | Kovacic JC et al. | β | 2011 | β |
| Cerebrovascular challenges in diabetic patients: the pressure is on to maintain perfusion. | Barnes JN et al. | β | 2011 | β |
| Changes in vascular risk factors from midlife to late life and white matter lesions: a 20-year follow-up study. | Vuorinen M et al. | β | 2011 | β |
| Current serum lipoprotein levels and FMRI response to working memory in midlife. | Gonzales MM et al. | β | 2011 | β |
| [Dementia and dyslipidemia]. | Tamaoka A | β | 2011 | β |
| Epidemiology of Alzheimer disease. | Reitz C et al. | β | 2011 | β |
| Evaluation of the effect of systolic blood pressure and pulse pressure on cognitive function: the Women's Health and Aging Study II. | Yasar S et al. | β | 2011 | β |
| Evaluation of the global association between cholesterol-associated polymorphisms and Alzheimer's disease suggests a role for rs3846662 and HMGCR splicing in disease risk. | Simmons CR et al. | β | 2011 | β |
| Fast and robust extraction of hippocampus from MR images for diagnostics of Alzheimer's disease. | LΓΆtjΓΆnen J et al. | β | 2011 | β |
| High alcohol consumption in middle-aged adults is associated with poorer cognitive performance only in the low socio-economic group. Results from the GAZEL cohort study. | Sabia S et al. | β | 2011 | β |
| Impaired cognition preceding cardiac surgery is related to cerebral ischemic lesions. | Maekawa K et al. | β | 2011 | β |
| Marked accumulation of 27-hydroxycholesterol in the brains of Alzheimer's patients with the Swedish APP 670/671 mutation. | Shafaati M et al. | β | 2011 | β |
| Metabolome in progression to Alzheimer's disease. | OreΕ‘iΔ M et al. | β | 2011 | β |
| Midlife healthy-diet index and late-life dementia and Alzheimer's disease. | Eskelinen MH et al. | β | 2011 | β |
| Mild cognitive impairment and dementia: the importance of modifiable risk factors. | Etgen T et al. | β | 2011 | β |
| New insights into Alzheimer's disease progression: a combined TMS and structural MRI study. | Niskanen E et al. | β | 2011 | β |
| Objective and subjective memory impairment in elderly adults: a revised version of the Everyday Memory Questionnaire. | Calabria M et al. | β | 2011 | β |
| Occurrence of medical co-morbidity in mild cognitive impairment: implications for generalisation of MCI research. | Stephan BC et al. | β | 2011 | β |
| Perimenopause and cognition. | Greendale GA et al. | β | 2011 | β |
| Predictive utility of the Framingham general cardiovascular disease risk profile for cognitive function: evidence from the Whitehall II study. | Kaffashian S et al. | β | 2011 | β |
| Preliminary findings from an internet-based dementia risk assessment. | Brandt J et al. | β | 2011 | β |
| Subjective memory complaints, vascular risk factors and psychological distress in the middle-aged: a cross-sectional study. | Paradise MB et al. | β | 2011 | β |
| The prevalence of mild cognitive impairment about elderly population in China: a meta-analysis. | Nie H et al. | β | 2011 | β |
| Validity of the montreal cognitive assessment (MoCA) as a screening test for mild cognitive impairment (MCI) in a cardiovascular population. | McLennan SN et al. | β | 2011 | β |
| Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. | Gorelick PB et al. | β | 2011 | β |
| Vascular risk factors and cognitive impairment in a stroke-free cohort. | Unverzagt FW et al. | β | 2011 | β |
| Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease. | Li J et al. | β | 2011 | β |
| Weight change and cognitive function: findings from the Women's Health Initiative Study of Cognitive Aging. | Driscoll I et al. | β | 2011 | β |
| Why physiology matters in medicine. | Joyner MJ | β | 2011 | β |
| Apolipoprotein A-I deficiency increases cerebral amyloid angiopathy and cognitive deficits in APP/PS1DeltaE9 mice. | Lefterov I et al. | β | 2010 | β |
| Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease. | Reitz C et al. | β | 2010 | β |
| Caffeine protects against disruptions of the blood-brain barrier in animal models of Alzheimer's and Parkinson's diseases. | Chen X et al. | β | 2010 | β |
| CHOLESTEROL AND NEURONAL SUSCEPTIBILITY TO BETA-AMYLOID TOXICITY. | Nicholson AM et al. | β | 2010 | β |
| Diagnostic correlates of Alzheimer dementia in a U.S. Nationwide inpatient sample. | Preuss UW et al. | β | 2010 | β |
| Diet and age interactions with regards to cholesterol regulation and brain pathogenesis. | Uranga RM et al. | β | 2010 | β |
| Different strategies for auditory word recognition in healthy versus normal aging. | Aine CJ et al. | β | 2010 | β |
| Effects of cholesterol and its 24S-OH and 25-OH oxysterols on choline acetyltransferase-positive neurons in brain slices. | Ullrich C et al. | β | 2010 | β |
| Efficacy of akatinol memantine in moderate cognitive impairments. | Levin OS et al. | β | 2010 | β |
| Genetic connections between neurological disorders and cholesterol metabolism. | BjΓΆrkhem I et al. | β | 2010 | β |
| Homocysteine and holotranscobalamin and the risk of Alzheimer disease: a longitudinal study. | Hooshmand B et al. | β | 2010 | β |
| Inflammatory brain injury after cardiopulmonary bypass: is it real? | Nussmeier NA et al. | β | 2010 | β |
| Interactions of estradiol and insulin-like growth factor-I signalling in the nervous system: new advances. | Garcia-Segura LM et al. | β | 2010 | β |
| Lowering midlife levels of systolic blood pressure as a public health strategy to reduce late-life dementia: perspective from the Honolulu Heart Program/Honolulu Asia Aging Study. | Launer LJ et al. | β | 2010 | β |
| Obesity, smoking, and frontal brain dysfunction. | Bauer L et al. | β | 2010 | β |
| Polyunsaturated fatty acids and reduced odds of MCI: the Mayo Clinic Study of Aging. | Roberts RO et al. | β | 2010 | β |
| Prevalence of mild cognitive impairment is higher in men. The Mayo Clinic Study of Aging. | Petersen RC et al. | β | 2010 | β |
| Relationship of hypertension, blood pressure, and blood pressure control with white matter abnormalities in the Women's Health Initiative Memory Study (WHIMS)-MRI trial. | Kuller LH et al. | β | 2010 | β |
| Risk factors for incident mild cognitive impairment--results from the German Study on Ageing, Cognition and Dementia in Primary Care Patients (AgeCoDe). | Luck T et al. | β | 2010 | β |
| Role of vascular risk factors and vascular dysfunction in Alzheimer's disease. | Dickstein DL et al. | β | 2010 | β |
| The effect of midlife physical activity on structural brain changes in the elderly. | Rovio S et al. | β | 2010 | β |
| The effects of cholesterol on learning and memory. | Schreurs BG | β | 2010 | β |
| The role of adipose tissue and adipokines in obesity-related inflammatory diseases. | Balistreri CR et al. | β | 2010 | β |
| Vascular risk factors: imaging and neuropathologic correlates. | Knopman DS et al. | β | 2010 | β |
| Age-related influence of the HDL receptor SR-BI on synaptic plasticity and cognition. | Chang EH et al. | β | 2009 | β |
| Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease. | Roher AE et al. | β | 2009 | β |
| Apolipoprotein C3 polymorphisms, cognitive function and diabetes in Caribbean origin Hispanics. | Smith CE et al. | β | 2009 | β |
| Association between mid-life marital status and cognitive function in later life: population based cohort study. | HΓ₯kansson K et al. | β | 2009 | β |
| Association of higher diastolic blood pressure levels with cognitive impairment. | Tsivgoulis G et al. | β | 2009 | β |
| Beyond mild cognitive impairment: vascular cognitive impairment, no dementia (VCIND). | Stephan BC et al. | β | 2009 | β |
| Blood pressure and the risk for dementia: a double edged sword. | Kennelly SP et al. | β | 2009 | β |
| Body mass index over the adult life course and cognition in late midlife: the Whitehall II Cohort Study. | Sabia S et al. | β | 2009 | β |
| Chronic kidney disease is associated with incident cognitive impairment in the elderly: the INVADE study. | Etgen T et al. | β | 2009 | β |
| Clinical field-strength MRI of amyloid plaques induced by low-level cholesterol feeding in rabbits. | Ronald JA et al. | β | 2009 | β |
| Cognitive impairment and hypertension among Chinese nonagenarians and centenarians. | Huang CQ et al. | β | 2009 | β |
| Cumulative exposure to high-strain and active jobs as predictors of cognitive function: the Whitehall II study. | Elovainio M et al. | β | 2009 | β |
| Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study. | Knopman DS et al. | β | 2009 | β |
| Health behaviors from early to late midlife as predictors of cognitive function: The Whitehall II study. | Sabia S et al. | β | 2009 | β |
| Homocysteine and holo-transcobalamin and the risk of dementia and Alzheimers disease: a prospective study. | Kivipelto M et al. | β | 2009 | β |
| Hypertension and cognitive function. | Obisesan TO | β | 2009 | β |
| Membrane-targeted strategies for modulating APP and Abeta-mediated toxicity. | Price KA et al. | β | 2009 | β |
| Mild behavioral impairment and risk of dementia: a prospective cohort study of 358 patients. | Taragano FE et al. | β | 2009 | β |
| Modifiable Midlife Risk Factors for Late-Life Cognitive Impairment and Dementia. | Hughes TF et al. | β | 2009 | β |
| Montreal Cognitive Assessment Arabic version: reliability and validity prevalence of mild cognitive impairment among elderly attending geriatric clubs in Cairo. | Rahman TT et al. | β | 2009 | β |
| Prevalence of dementia and cognitive impairment in Southeastern Spain: the Ariadna study. | Gavrila D et al. | β | 2009 | β |
| Structural neuroimaging in Altheimer's disease: do white matter hyperintensities matter? | Brickman AM et al. | β | 2009 | β |
| The effects of cardiovascular risk factors on cognitive compromise. | Beeri MS et al. | β | 2009 | β |
| The influence of age on the association between cholesterol and cognitive function. | van Vliet P et al. | β | 2009 | β |
| Vascular risk factors and cognitive functions in nondemented elderly individuals. | Wiederkehr S et al. | β | 2009 | β |
| Abnormal regional cerebral blood flow in cognitively normal elderly subjects with hypertension. | Dai W et al. | β | 2008 | β |
| Apolipoprotein E and cholesterol in aging and disease in the brain. | de Chaves EP et al. | β | 2008 | β |
| Blood pressure is associated with cognitive impairment in young hypertensives. | Gupta R et al. | β | 2008 | β |
| Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: a critical review. | Sherwin BB et al. | β | 2008 | β |
| Cardiovascular risk factors and dementia. | Fillit H et al. | β | 2008 | β |
| Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis. | Anstey KJ et al. | β | 2008 | β |
| Dementia prevention: methodological explanations for inconsistent results. | Coley N et al. | β | 2008 | β |
| Depressive symptoms, vascular risk factors and mild cognitive impairment. The Italian longitudinal study on aging. | Panza F et al. | β | 2008 | β |
| [Effects of long-term antihypertensive therapy with losartan on blood pressure and cognitive function in patients with essential hypertension and other cerebrovascular risk factors (AWARE observational study)]. | Schrader J et al. | β | 2008 | β |
| Fat intake at midlife and cognitive impairment later in life: a population-based CAIDE study. | Eskelinen MH et al. | β | 2008 | β |
| Growing old with epilepsy: the neglected issue of cognitive and brain health in aging and elder persons with chronic epilepsy. | Hermann B et al. | β | 2008 | β |
| HDL-replacement therapy: mechanism of action, types of agents and potential clinical indications. | Remaley AT et al. | β | 2008 | β |
| High blood pressure, hypertension, and high pulse pressure are associated with poorer cognitive function in persons aged 60 and older: the Third National Health and Nutrition Examination Survey. | Obisesan TO et al. | β | 2008 | β |
| Higher cardiovascular risk in midlife is associated with worse cognitive function 29 years later, in old age. | Rantanen K et al. | β | 2008 | β |
| High-normal blood pressure is associated with poor cognitive performance. | Knecht S et al. | β | 2008 | β |
| Hypercholesterolemia-induced Abeta accumulation in rabbit brain is associated with alteration in IGF-1 signaling. | Sharma S et al. | β | 2008 | β |
| [Hypertension and cognitive function]. | Casado Naranjo I et al. | β | 2008 | β |
| Impact of depressive symptoms on the rate of progression to dementia in patients affected by mild cognitive impairment. The Italian Longitudinal Study on Aging. | Panza F et al. | β | 2008 | β |
| Kidney function and cognitive impairment in US adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. | Kurella Tamura M et al. | β | 2008 | β |
| Mild cognitive impairment: epidemiology and dementia risk in an elderly Italian population. | Ravaglia G et al. | β | 2008 | β |
| MRI of hippocampus and entorhinal cortex in mild cognitive impairment: a follow-up study. | Tapiola T et al. | β | 2008 | β |
| Oxidative stress related changes in the brain of hypercholesterolemic rabbits. | Aytan N et al. | β | 2008 | β |
| Plasma lipid levels in the elderly are not associated with the risk of mild cognitive impairment. | Reitz C et al. | β | 2008 | β |
| Potential mechanisms linking cholesterol to Alzheimer's disease-like pathology in rabbit brain, hippocampal organotypic slices, and skeletal muscle. | Ghribi O | β | 2008 | β |
| The International Network on Public Health and Aging (INOPA): introducing a life course perspective to the public health agenda. | Wahlin A et al. | β | 2008 | β |
| Vascular risk factors and Alzheimer's disease. | Cechetto DF et al. | β | 2008 | β |
| Alcohol drinking and cognitive functions: findings from the Cardiovascular Risk Factors Aging and Dementia (CAIDE) Study. | Ngandu T et al. | β | 2007 | β |
| Alzheimer's disease and cholesterol: the fat connection. | Canevari L et al. | β | 2007 | β |
| Blood pressure treatment and cognition in the elderly. | Paran E et al. | β | 2007 | β |
| Carotid intima-media thickness and cognitive function in elderly women: a population-based study. | Komulainen P et al. | β | 2007 | β |
| Characterization of the lipid profile in dementia and depression in the elderly. | Dimopoulos N et al. | β | 2007 | β |
| Cholesterol and triglycerides moderate the effect of apolipoprotein E on memory functioning in older adults. | de Frias CM et al. | β | 2007 | β |
| Cholesterol level, statin use and Alzheimer's disease in adults with Down syndrome. | Zigman WB et al. | β | 2007 | β |
| Decreased cerebral blood flow velocity in apolipoprotein E epsilon4 allele carriers with mild cognitive impairment. | Sun ZW et al. | β | 2007 | β |
| Education and dementia: what lies behind the association? | Ngandu T et al. | β | 2007 | β |
| Effect of HMG-CoA reductase inhibitors on beta-amyloid peptide levels: implications for Alzheimer's disease. | HΓΆglund K et al. | β | 2007 | β |
| Event related brain potentials in elderly patients with recently diagnosed isolated systolic hypertension. | Cicconetti P et al. | β | 2007 | β |
| Frequency of subclinical heart disease in elderly persons with dementia. | Reitz C et al. | β | 2007 | β |
| Heritability of magnetic resonance imaging (MRI) traits in Alzheimer disease cases and their siblings in the MIRAGE study. | Lunetta KL et al. | β | 2007 | β |
| Heterogeneity in risk factors for cognitive impairment, no dementia: population-based longitudinal study from the Kungsholmen Project. | Monastero R et al. | β | 2007 | β |
| High dietary cholesterol facilitates classical conditioning of the rabbit's nictitating membrane response. | Schreurs BG et al. | β | 2007 | β |
| Increased cholesterol in Abeta-positive nerve terminals from Alzheimer's disease cortex. | Gylys KH et al. | β | 2007 | β |
| Less atherosclerosis and lower blood pressure for a meaningful life perspective with more brain. | Staessen JA et al. | β | 2007 | β |
| Low systolic blood pressure is associated with impaired cognitive function in the oldest old: longitudinal observations in a population-based sample 80 years and older. | Nilsson SE et al. | β | 2007 | β |
| Measures of adiposity and dementia risk in elderly persons. | Luchsinger JA et al. | β | 2007 | β |
| Mild cognitive impairment. | Amar K et al. | β | 2007 | β |
| Mild cognitive impairment in symptomatic and asymptomatic cerebrovascular disease. | PopoviΔ IM et al. | β | 2007 | β |
| Preexisting cognitive impairment in patients scheduled for elective coronary artery bypass graft surgery. | Silbert BS et al. | β | 2007 | β |
| Prevention and treatment of dementia or Alzheimer's disease by statins: a meta-analysis. | Zhou B et al. | β | 2007 | β |
| Relation of Blood Pressure to Cognitive Impairment and Dementia. | Reitz C et al. | β | 2007 | β |
| Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study. | Solomon A et al. | β | 2007 | β |
| The metabolic syndrome is associated with decelerated cognitive decline in the oldest old. | van den Berg E et al. | β | 2007 | β |
| Usefulness of ARBs and ACE inhibitors in the prevention of vascular dementia in the elderly. | Hanes DS et al. | β | 2007 | β |
| Vascular risk factors and intensity of cognitive dysfunction in MCI. | Siuda J et al. | β | 2007 | β |
| Vascular risk factors and white matter hyperintensities in patients with amnestic mild cognitive impairment. | Sepe-Monti M et al. | β | 2007 | β |
| Vascular risk factors in mild cognitive impairment subtypes. Findings from the ReGAl project. | Mariani E et al. | β | 2007 | β |
| Voxel-based morphometry to detect brain atrophy in progressive mild cognitive impairment. | HΓ€mΓ€lΓ€inen A et al. | β | 2007 | β |
| A life-course approach to the aetiology of late-onset dementias. | Whalley LJ et al. | β | 2006 | β |
| Antihypertensive medication is associated with less cognitive impairment in the very old with apolipoprotein-E epsilon4 allele. | Hestad KA et al. | β | 2006 | β |
| A pilot study evaluating the efficacy and safety of rivastigmine in patients with mixed dementia. | Potkin SG et al. | β | 2006 | β |
| Apolipoprotein E, angiotensin-converting enzyme and kallikrein gene polymorphisms and the risk of Alzheimer's disease and vascular dementia. | Wang HK et al. | β | 2006 | β |
| Cholesterol, statins and tau. | Ohm TG et al. | β | 2006 | β |
| Circulating biomarkers of cognitive decline and dementia. | Solfrizzi V et al. | β | 2006 | β |
| Cognitive frailty: Predementia syndrome and vascular risk factors. | Panza F et al. | β | 2006 | β |
| Effect of statins on beta-amyloid metabolism in humans: potential importance for the development of senile plaques in Alzheimer's disease. | HΓΆglund K et al. | β | 2006 | β |
| Fat intake at midlife and risk of dementia and Alzheimer's disease: a population-based study. | Laitinen MH et al. | β | 2006 | β |
| Interaction of cardiovascular disease and neurodegeneration: transcranial Doppler ultrasonography and Alzheimer's disease. | Roher AE et al. | β | 2006 | β |
| Lipid metabolism in cognitive decline and dementia. | Panza F et al. | β | 2006 | β |
| Mild cognitive impairment and the 7 uses of epidemiology. | Ganguli M | β | 2006 | β |
| Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease. | Levey A et al. | β | 2006 | β |
| Oxidative stress in Alzheimer's disease. | Chauhan V et al. | β | 2006 | β |
| Pharmacological treatment of non-Alzheimer dementias. | Arlt S et al. | β | 2006 | β |
| Prevalence and persistence of mild cognitive impairment among elderly patients in general hospitals. | Bickel H et al. | β | 2006 | β |
| Progress in cardiovascular diseases: cognitive function in essential hypertension. | BirkenhΓ€ger WH et al. | β | 2006 | β |
| Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. | Kivipelto M et al. | β | 2006 | β |
| Role of cholesterol in amyloid cascade: cholesterol-dependent modulation of tau phosphorylation and mitochondrial function. | Michikawa M | β | 2006 | β |
| Stroke and memory performance in elderly persons without dementia. | Reitz C et al. | β | 2006 | β |
| The effect of apolipoprotein polymorphism on brain in mild cognitive impairment: a voxel-based morphometric study. | Pennanen C et al. | β | 2006 | β |
| The state of mental health in old-age across the 'old' European Union-- a systematic review. | Riedel-Heller SG et al. | β | 2006 | β |
| Arterial pulse wave velocity as a marker of poor cognitive function in an elderly community-dwelling population. | Fujiwara Y et al. | β | 2005 | β |
| Arterial stiffness is an independent risk factor for cognitive impairment in the elderly: a pilot study. | Scuteri A et al. | β | 2005 | β |
| A voxel based morphometry study on mild cognitive impairment. | Pennanen C et al. | β | 2005 | β |
| Cardiovascular risk factors and cognitive function in adults 30-59 years of age (NHANES III). | Pavlik VN et al. | β | 2005 | β |
| Cholesterol and apolipoprotein E in Alzheimer's disease. | Reiss AB | β | 2005 | β |
| Cholesterol in Alzheimer's disease. | Shobab LA et al. | β | 2005 | β |
| Cognitive function predicts first-time stroke and heart disease. | Elkins JS et al. | β | 2005 | β |
| Contributors to white matter damage in the frontal lobe in Alzheimer's disease. | Chalmers K et al. | β | 2005 | β |
| Current epidemiology of mild cognitive impairment and other predementia syndromes. | Panza F et al. | β | 2005 | β |
| Diabetes and brain aging: epidemiologic evidence. | Launer LJ | β | 2005 | β |
| Does the level of LDL cholesterol moderate a relationship between DRD4 and novelty seeking? | Elovainio M et al. | β | 2005 | β |
| Hypertension and cognitive decline: impact on executive function. | Vicario A et al. | β | 2005 | β |
| Hypertension and cognitive functioning among the elderly: an overview. | Anson O et al. | β | 2005 | β |
| Impact of hypertension and apolipoprotein E4 on poststroke cognition in subjects >75 years of age. | Rowan E et al. | β | 2005 | β |
| Inhibition of vascular nitric oxide after rat chronic brain hypoperfusion: spatial memory and immunocytochemical changes. | de la Torre JC et al. | β | 2005 | β |
| Is vascular depression a distinct sub-type of depressive disorder? A review of causal evidence. | Baldwin RC | β | 2005 | β |
| Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease. | Rovio S et al. | β | 2005 | β |
| Lipid lowering agents are associated with a slower cognitive decline in Alzheimer's disease. | Masse I et al. | β | 2005 | β |
| Low blood pressure is a better predictor of cognitive deficits than the apolipoprotein e4 allele in the oldest old. | Hestad K et al. | β | 2005 | β |
| Measures of brain morphology and infarction in the framingham heart study: establishing what is normal. | DeCarli C et al. | β | 2005 | β |
| Neurocognitive testing supports a broader concept of mild cognitive impairment. | Gualtieri CT et al. | β | 2005 | β |
| Relationship between DRD4 polymorphism and lipid metabolism: what is the role of novelty seeking? | Elovainio M et al. | β | 2005 | β |
| Serum cholesterol and cognitive performance in the Framingham Heart Study. | Elias PK et al. | β | 2005 | β |
| Serum cholesterol and risk of Alzheimer disease: a community-based cohort study. | Li G et al. | β | 2005 | β |
| Sexual dysfunction in male patients with hypertension: influence of antihypertensive drugs. | DΓΌsing R | β | 2005 | β |
| Statins and cognitive function in the elderly: the Cardiovascular Health Study. | Bernick C et al. | β | 2005 | β |
| The age-dependent relation of blood pressure to cognitive function and dementia. | Qiu C et al. | β | 2005 | β |
| The epidemiologic study of dementia: a life-long quest? | Launer LJ | β | 2005 | β |
| The Goteborg MCI study: mild cognitive impairment is a heterogeneous condition. | Nordlund A et al. | β | 2005 | β |
| Alcohol drinking in middle age and subsequent risk of mild cognitive impairment and dementia in old age: a prospective population based study. | Anttila T et al. | β | 2004 | β |
| Alzheimer disease risk and genetic variation in ACE: a meta-analysis. | Elkins JS et al. | β | 2004 | β |
| Alzheimer's disease is a vasocognopathy: a new term to describe its nature. | de la Torre JC | β | 2004 | β |
| APP and PS-1 mutations induce brain oxidative stress independent of dietary cholesterol: implications for Alzheimer's disease. | Mohmmad Abdul H et al. | β | 2004 | β |
| Associations among plasma lipoprotein subfractions as characterized by analytical capillary isotachophoresis, apolipoprotein E phenotype, Alzheimer disease, and mild cognitive impairment. | Zhang B et al. | β | 2004 | β |
| Atherosclerosis, vascular amyloidosis and brain hypoperfusion in the pathogenesis of sporadic Alzheimer's disease. | Kalback W et al. | β | 2004 | β |
| Cholesterol-independent effects of statins and new therapeutic targets: ischemic stroke and dementia. | Miida T et al. | β | 2004 | β |
| Hippocampus and entorhinal cortex in mild cognitive impairment and early AD. | Pennanen C et al. | β | 2004 | β |
| Life long changes in cognitive ability are associated with prescribed medications in old age. | Starr JM et al. | β | 2004 | β |
| Links between the pathology of Alzheimer's disease and vascular dementia. | Sadowski M et al. | β | 2004 | β |
| [Loss of motivation and frontal dysfunction. Role of the white matter change]. | Thomas P et al. | β | 2004 | β |
| Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia. | DeCarli C et al. | β | 2004 | β |
| Mild cognitive impairment, amnestic type: an epidemiologic study. | Ganguli M et al. | β | 2004 | β |
| Pharmacotherapeutic approaches to the prevention of Alzheimer's disease. | Standridge JB | β | 2004 | β |
| Randomized trial of the effects of simvastatin on cognitive functioning in hypercholesterolemic adults. | Muldoon MF et al. | β | 2004 | β |
| Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. | Dietschy JM et al. | β | 2004 | β |
| The nature and effects of cortical microvascular pathology in aging and Alzheimer's disease. | Bailey TL et al. | β | 2004 | β |
| The prevalence of "cognitive impairment no dementia" in community-dwelling elderly: a pilot study. | Low LF et al. | β | 2004 | β |
| Undiagnosed diseases in patients with dementia--a potential target group for intervention. | LΓΆppΓΆnen MK et al. | β | 2004 | β |
| Vascular factors in dementia: an overview. | Decarli C | β | 2004 | β |
| Vascular risk factors, incidence of MCI, and rates of progression to dementia. | Solfrizzi V et al. | β | 2004 | β |
| Association of aortic atherosclerosis with cerebral beta-amyloidosis and learning deficits in a mouse model of Alzheimer's disease. | Li L et al. | β | 2003 | β |
| Changes in apolipoprotein E expression in response to dietary and pharmacological modulation of cholesterol. | Petanceska SS et al. | β | 2003 | β |
| Cholesterol modifies classical conditioning of the rabbit (Oryctolagus cuniculus) nictitating membrane response. | Schreurs BG et al. | β | 2003 | β |
| Cholesterol paradox: is high total or low HDL cholesterol level a risk for Alzheimer's disease? | Michikawa M | β | 2003 | β |
| Circle of willis atherosclerosis is a risk factor for sporadic Alzheimer's disease. | Roher AE et al. | β | 2003 | β |
| Combined uridine and choline administration improves cognitive deficits in spontaneously hypertensive rats. | De Bruin NM et al. | β | 2003 | β |
| Epidemiology of neurodegeneration. | Mayeux R | β | 2003 | β |
| Mild cognitive impairment: prevalence and incidence according to different diagnostic criteria. Results of the Leipzig Longitudinal Study of the Aged (LEILA75+). | Busse A et al. | β | 2003 | β |
| Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment. | DeCarli C | β | 2003 | β |
| Plasma vitamin C, cholesterol and homocysteine are associated with grey matter volume determined by MRI in non-demented old people. | Whalley LJ et al. | β | 2003 | β |
| Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. | Chobanian AV et al. | β | 2003 | β |
| The role of cerebrovascular disease in dementia. | DeCarli C | β | 2003 | β |
| The role of cholesterol in pathogenesis of Alzheimer's disease: dual metabolic interaction between amyloid beta-protein and cholesterol. | Michikawa M | β | 2003 | β |
| Vascular dementia. | Strub RL | β | 2003 | β |
| Vascular dementia. | Strub R | β | 2003 | β |
| Alzheimer disease as a vascular disorder: nosological evidence. | de la Torre JC | β | 2002 | β |
| Apolipoprotein E (ApoE) isoform-dependent lipid release from astrocytes prepared from human ApoE3 and ApoE4 knock-in mice. | Gong JS et al. | β | 2002 | β |
| Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease. | Kivipelto M et al. | β | 2002 | β |
| Are antihypertensive agents protective against dementia? A review of clinical and preclinical data. | Frishman WH | β | 2002 | β |
| Cholesterol and pathological processes in Alzheimer's disease. | Yanagisawa K | β | 2002 | β |
| Cholesterol, oxidative stress, and Alzheimer's disease: expanding the horizons of pathogenesis. | Pappolla MA et al. | β | 2002 | β |
| Novel therapeutic strategies provide the real test for the amyloid hypothesis of Alzheimer's disease. | Dominguez DI et al. | β | 2002 | β |
| The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function. | Posner HB et al. | β | 2002 | β |
| Vascular basis of Alzheimer's pathogenesis. | de la Torre JC | β | 2002 | β |
| Cholesterol and Alzheimer's disease: is there a link? | Simons M et al. | β | 2001 | β |